[HTML][HTML] CT features of HER2-mutant lung adenocarcinomas
Objectives To describe the radiological phenotype of HER2-mutant lung cancers on CT at
presentation. Methods Eligible patients with lung adenocarcinomas with HER2 mutations …
presentation. Methods Eligible patients with lung adenocarcinomas with HER2 mutations …
[HTML][HTML] CT features of HER2-mutant lung adenocarcinomas
P Sawan, AJ Plodkowski, AE Li, BT Li, A Drilon… - Clinical …, 2018 - ncbi.nlm.nih.gov
Objectives: To describe the radiological phenotype of HER2-mutant lung cancers on CT at
presentation. Methods: Eligible patients with lung adenocarcinomas with HER2 mutations …
presentation. Methods: Eligible patients with lung adenocarcinomas with HER2 mutations …
CT features of HER2-mutant lung adenocarcinomas.
P Sawan, AJ Plodkowski, AE Li, BT Li, A Drilon… - Clinical …, 2018 - europepmc.org
OBJECTIVES: To describe the radiological phenotype of HER2-mutant lung cancers on CT
at presentation. METHODS: Eligible patients with lung adenocarcinomas with HER2 …
at presentation. METHODS: Eligible patients with lung adenocarcinomas with HER2 …
[HTML][HTML] CT features of HER2-mutant lung adenocarcinomas
P Sawan, AJ Plodkowski, AE Li, BT Li, A Drilon… - Clinical …, 2018 - clinicalimaging.org
Objectives To describe the radiological phenotype of HER2-mutant lung cancers on CT at
presentation. Methods Eligible patients with lung adenocarcinomas with HER2 mutations …
presentation. Methods Eligible patients with lung adenocarcinomas with HER2 mutations …
CT features of HER2-mutant lung adenocarcinomas
P Sawan, AJ Plodkowski, AE Li, BT Li… - Clinical …, 2018 - pubmed.ncbi.nlm.nih.gov
Objectives To describe the radiological phenotype of HER2-mutant lung cancers on CT at
presentation. Methods Eligible patients with lung adenocarcinomas with HER2 mutations …
presentation. Methods Eligible patients with lung adenocarcinomas with HER2 mutations …